68135-020Level 3
NAGLAZYME (galsulfase)
**Product type:** Human Prescription Drug
**Active ingredient:** GALSULFASE
**Strength:** 5 mg/5mL
**Dosage form:** Solution
**Route:** Intravenous
**Labeler:** BioMarin Pharmaceutical Inc.
**Marketing category:** BLA (BLA125117)
**Pharmacologic class:** Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC], alpha-Glucosidases [CS]
GET
/api/v1/systems/ndc_fda/nodes/68135-020Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.